Evaluation of the Response to Ranibizumab Therapy following Bevacizumab Treatment Failure in Eyes with Diabetic Macular Edema

Evaluation of the Response to Ranibizumab Therapy following Bevacizumab Treatment Failure in Eyes with Diabetic Macular Edema

Background/Aims: Bevacizumab and ranibizumab are routinely used to treat diabetic macular edema (DME). We aim to evaluate the usefulness of switching to ranibizumab therapy following bevacizumab treatment failure in eyes with DME. Methods: We performed a retrospective analysis of a consecutive group...

Full description

Bibliographic Details
Main Authors: Joel Hanhart, Itay Chowers
Format: Article
Language:English
Published: Karger Publishers 2015-02-01
Series:Case Reports in Ophthalmology
Subjects:
Diabetic macular edema
Ranibizumab
Bevacizumab
Treatment failure
Online Access:http://www.karger.com/Article/FullText/375230

Similar Items

Similar Items